Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare AWP Reform Could Pay For Oral Cancer Drug Coverage

Executive Summary

Medicare AWP payment reform could free up funds to expand coverage of oral anticancer drugs, former Health Care Financing Administration head Nancy-Ann DeParle told the JP Morgan H&Q healthcare conference Jan. 7 in San Francisco

You may also be interested in...



Oral Cancer Drug Coverage Bill May Move In Combo With AWP Reform

Sen. John Rockefeller (D-W.Va.) would like to tie a bill providing for Medicare coverage of oral cancer therapies with reform of the AWP reimbursement system for drugs already covered by Medicare

Oral Cancer Drug Coverage Bill May Move In Combo With AWP Reform

Sen. John Rockefeller (D-W.Va.) would like to tie a bill providing for Medicare coverage of oral cancer therapies with reform of the AWP reimbursement system for drugs already covered by Medicare

Medicare Rx: Rep. Johnson To Introduce Drug/Reform Bill In 2002

The Medicare prescription drug benefit debate in 2002 will kick off in the House with the expected introduction of a bill by Rep. Nancy Johnson (R-Conn.)

Related Content

UsernamePublicRestriction

Register

PS039141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel